Abstract: A prodrug formed by a compound including a pharmaceutically active antioxidant molecule which is covalently coupled, via a bond comprising at least one carboxylic ester group, to a nucleoside devoid of free hydroxyl and primary amine functions, comprising a ribose or deoxyribose unit covalently bonded to a nucleic base, this nucleoside bearing at least one lipidising group. A pharmaceutical composition which is particularly useful for therapeutic uses contains this prodrug in a nanoemulsion, in which the prodrug is contained in the lipophilic phase.

Abstract: The invention concerns a biocompatible oily ferrofluid comprising iron-oxide based magnetic nanoparticles and an oil phase comprising at least one fatty acid ester, characterized in that said magnetic nanoparticles are surface functionalized by molecules of one or more phospholipids, and in particular a biocompatible oily ferrofluid comprising iron-oxide based magnetic nanoparticles and an oil phase comprising at least one fatty acid ester, said iron-oxide based magnetic nanoparticles forming a colloidal dispersion in said oil phase from a temperature belonging to the range from 20 to 80° C.

Abstract: The invention relates to a method for decontaminating an aqueous liquid medium containing molecular micropollutants or a surface contaminated with micropollutants using nucleolipid compounds.